
| Public education in rational drug use: A global survey (WHO/DAP, 1997, 97 p.) |
|
N°. 1 |
Injection practices research |
|
N°. 2 |
How to investigate drug use in communities (available also in French) |
|
N°. 3 |
Operational research on the rational use of drugs |
|
N°. 4 |
Development of indicators for monitoring national drug policies |
|
N°. 5 |
People's perception and use of drugs in Zimbabwe |
|
N°. 6 |
Operational research in the Action Programme on Essential Drugs: Report of an informal consultation |
|
N°. 7 |
How to investigate drug use in health facilities: Selected drug use indicators (available also in French and Spanish) |
|
N°. 8 |
Stability of injectable oxytocics in tropical climates: Results of field surveys and simulation studies on ergometrine, methylergometrine and oxytocin |
|
N°. 9 |
Prescription des antibiotiques dans trois pays d'Afrique de l'Ouest Mauritanie, Niger et Sénégal |
|
N°. 10 |
Self-medication and its impact on essential drugs schemes in Nepal |
|
N°. 11 |
Injection practices: A case study in Thailand |
|
N°. 12 |
Stability of oral oxytocics in tropical climates |
|
N°. 13 |
Stability of essential drugs in tropical climates: Zimbabwe |
|
N°. 14 |
Injection use and practices in Uganda |
|
N°. 15 |
Community health workers and drugs: A case study of Thailand |
|
N°. 16 |
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce |
|
N°. 17 |
Impact of a short course in pharmacotherapy for undergraduate medical students: An international multicentre study |
|
N°. 18 |
La qualité des médicaments sur le marché pharmaceutique
africain |
|
N°. 19 |
Operational research projects in the Action Programme on Essential Drugs: An annotated inventory |
|
N°. 20 |
Injection Practices in the Developing World |
|
N°. 21 |
Le secteur pharmaceutique privé commercial au Maroc: dynamique de développement et effets sur l'accessibilité des médicaments essentiels |
|
N°. 22 |
La liberalisation du secteur pharmacetique en Algérie: effets sur la disponibilité et les prix des médicaments |
|
N°. 23 |
Le secteur pharmaceutique privé commercial au Sénégal: logiques de développement et effets sur la disponibilité et l'accessibilité des médicaments essentiels |